Agenda for Meeting Four: Feb. 28-March 1, 2011, in Washington, D.C.

St. Regis Hotel
923 16th Street, NW
Washington, DC 20006
(202) 638-2626

Monday, February 28

9-9:15 a.m.

Welcome and Opening Remarks

  • Amy Gutmann, Ph.D.
    • Commission Chair
  • James Wagner, Ph.D.
    • Commission Vice Chair

9:15-9:45 a.m.

Session 1: Bioethics Research at NIH

  • Francis S. Collins, M.D., Ph.D.
    • Director
      National Institutes of Health

9:45-10:30 a.m.

Session 2: State of the Science

Neuroscience and Neuroimaging

  • Bruce R. Rosen, M.D., Ph.D.
    • Professor of Radiology
      Harvard Medical School
    • Director
      Athinoula A. Martinos Center for Biomedical Imaging
    • Department of Radiology
      Massachusetts General Hospital

Genetics

  • James P. Evans, M.D., Ph.D.
    • Clinical Professor and Bryson Distinguished Professor of Genetics and Medicine
      Department of Genetics, University of North Carolina, School of Medicine

10:30-10:45 a.m.

Break

10:45-11:45 a.m.

Session 3: Ethics of Emerging Diagnostic and Predictive Tools

  • Martha Farah, Ph.D.
    • Walter H. Annenberg Professor in Natural Sciences; Professor of Psychology; Director, Center for Cognitive Neuroscience; Director, Center for Neuroscience and Society; Senior Fellow, Center for Bioethics
      University of Pennsylvania
  • Hank Greely, J.D.
    • Deane F. and Kate Edelman Johnson Professor of Law
      Stanford Law School
    • Professor (by courtesy) of Genetics
      Stanford Medical School
    • Director
      Center for Law and the Biosciences
    • Director
      Stanford Interdisciplinary Group on Neuroscience and Society and its Program in Neuroethics
      Stanford Law School
    • Chair
      Steering Committee of the Center for Biomedical Ethics

11:45 a.m.-1:15 p.m.

Lunch Break

1:15-2:15 p.m.

Session 4: Current Issues in Genetics

  • Ellen Wright Clayton, J.D., M.D.
    • Craig-Weaver Professor of Pediatrics; Professor of Law; Director, Center for Biomedical Ethics and Society
      Vanderbilt University
  • Susan Wolf, J.D.
    • McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; Faculty Member, Center for Bioethics
      University of Minnesota
  • Erik Parens, Ph.D.
    • Senior Research Scholar
      The Hastings Center

2:15-2:30 p.m.

Break

2:30-3:30 p.m.

Session 5: Current Issues in Neuroscience and Neuroimaging

  • Judy Illes, Ph.D.
    • Professor of Neurology; Canada Research Chair in Neuroethics; Director, National Core for Neuroethics; Faculty, Brain Research Centre
      University of British Columbia
  • Stephen Morse, J.D., Ph.D.
    • Ferdinand Wakeman Hubbell Professor of Law and Professor of Psychology and Law in Psychiatry
      University of Pennsylvania Law School & School of Medicine
  • Adina Roskies, Ph.D.
    • Associate Professor, Department of Philosophy
      Dartmouth College

3:30-4:30 p.m.

Session 6: Roundtable

  • All Guest Speakers

4:30-4:45 p.m.

Closing Remarks

  • Amy Gutmann, Ph.D.
  • James Wagner, Ph.D.

Tuesday, March 1

9-9:30 a.m.

Opening Remarks and Executive Director’s Report

  • Amy Gutmann, Ph.D.
  • James Wagner, Ph.D.
  • Valerie H. Bonham, J.D.
    • Executive Director

9:30-10:30 a.m.

Session 7: Medical Research – The Global Landscape

  • Lawrence Corey, M.D.
    • President and Director
      Fred Hutchinson Cancer Research Center
    • Principal Investigator
      HIV Vaccine Trials Network
    • Professor, Laboratory Medicine and Medicine
      University of Washington
  • Robert M. Califf, M.D.
    • Vice Chancellor for Clinical Research
      Duke University
    • Professor of Medicine
      Duke University Medical Center
    • Director
      Duke Translational Medicine Institute

10:30-10:40 a.m.

Break

10:40-11:40 a.m.

Session 8: Social Justice and Ethics Issues

  • Susan E. Lederer, Ph.D.
    • Robert Turell Professor of History of Medicine and Bioethics and Chair, Medical History and Bioethics
      University of Wisconsin School of Medicine and Public Health
  • Dan W. Brock, Ph.D.
    • Frances Glessner Lee Professor of Medical Ethics, Department of Global Health and Social Medicine and Director, Division of Medical Ethics
      Harvard Medical School
  • Eric M. Meslin, Ph.D.
    • Director
      Indiana University Center for Bioethics
    • Dean (Bioethics) and Professor of Medicine, Medical and Molecular Genetics, Public Health, and Philosophy
      IU School of Medicine
    • Director
      Indiana University-Moi University Academic Research Ethics Partnership

11:40-11:50 a.m.

Break

11:50 a.m.-12:35 p.m.

Session 9: Roundtable

  • All Guest Speakers

12:35-1:20 p.m.

Session 10: Public Comment

1:20-1:30 p.m.

Concluding Remarks

  • Amy Gutmann, Ph.D.
  • James Wagner, Ph.D.

Topics

Day 1: Ethics of Genetics and Neuroimaging Testing

Day 2: Human Subjects Protection

Watch

Watch the archived video.

Share Your Views

The Commission welcomes input from anyone wishing to provide public comment on any issue before it. The Commission’s goal, time permitting, is to invite brief public comment during each meeting session.

Individuals who would like to provide public comment at the meeting should notify Esther Yoo by telephone at 202-233-3960, or e-mail at Esther.Yoo@bioethics.gov.

To accommodate as many speakers as possible the time for public comments may be limited. If the number of individuals wishing to speak is greater than can reasonably be accommodated during the scheduled meeting, the Commission may randomly select speakers from among those who register to speak.

Written comments will also be accepted and are especially welcome. Please address written comments by e-mail to info@bioethics.gov, or by mail to the following address:

Public Commentary
The Presidential Commission for the Study of Bioethical Issues
1425 New York Ave. NW, Suite C-100
Washington, DC 20005.

Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted.

Special Assistance

Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should also notify Esther Yoo (contact information above) in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance.